TIGIT, an immune checkpoint receptor, is co-expressed with PD-1 and LAG3 in exhausted T cells of patients with B-ALL [67], synergistically inhibiting T cell function. The gene discussed is TIGIT; the disease is acute lymphoblastic leukemia.